- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A paid media advisory board with journalists about brodalumab (pre-authorisation) was ruled promotional. Breaches of Clauses 3.1, 9.1 and 2; no breach…
PMCPA found Iluvien site landing page allowed public access to patient treatment support booklets (for prescribed patients), amounting to public promotion. Prescribing…
Anonymous doctor alleged a Pfizer rep used different names to secure appointments during Covid-19 restrictions, promoted Xeljanz off-licence for Covid-19/IBD, and suggested…
Complaint about 60 videos on LEO’s Global YouTube. Most out of UK Code scope, but breaches found for an HCP symposium video…
Complaint about Sanofi’s flu vaccine ordering communications and a 30% QIVe dose reduction (with QIVr as an alternative). Panel found no evidence…
An internal congratulatory email reproduced APC formulary wording inconsistent with Suliqua’s SPC, without an off-label warning. PMCPA ruled the email was briefing…
PMCPA found breaches on an HCP website where generic names were not readily readable and several “add-on”/dosing claims implied use with any…
A senior UK employee ‘liked’ a US surgeon’s LinkedIn post naming and praising unlicensed Durysta. The PMCPA ruled this proactively disseminated pre-authorisation…
Employee alleged Sanofi used Lantus rebates to block biosimilar uptake and ignored internal concerns. PMCPA found no evidence of anti-competitive breach or…
A corporate LinkedIn post named brands and an indication for a newly authorised SLIT tablet. PMCPA ruled this was POM promotion to…
Employee alleged disguised promotion in internal training using real HCPs, including role-plays with HCPs from reps’ own territories. Panel found bona fide…
A Monaco Letybo launch symposium at a prestigious five-star hotel, plus “Cocktails, Meeting & Dinner” signage, led the Panel to rule hospitality/venue…
Two reps sent a certified promotional supply-update email about Ozempic/Rybelsus but omitted key obligatory items (PI links, AE reporting, date). PMCPA ruled…
PMCPA found Teva in breach for DuoResp Spiromax website when viewed on mobile: mobile/desktop final forms differed but weren’t separately certified, and…
Kesimpta promo webpage implied unrestricted SMC approval (restriction not in immediate view). A UK HCP banner ad omitted “adult” from the licence…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.